Harbin Gloria Pharmaceuticals Co., Ltd Price (002437.SZ)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

2,199,893,718

(0.0806)%

Table Charts
Bar Charts

Revenue and Profitability

Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Revenue 164,113,010 275,610,229 429,928,954 575,448,365 546,364,548 711,030,303 1,307,886,246 1,905,823,991 2,681,225,307 2,983,728,136 3,041,883,453 5,481,339,828 5,053,859,894 3,054,949,266 3,145,311,703 3,107,945,160 2,626,039,306
Net Income 74,755,721 105,950,873 130,235,113 154,713,039 116,848,259 164,769,964 226,737,497 443,770,001 664,808,612 716,648,314 309,675,737 125,893,634 -2,654,938,126 400,049,122 45,042,024 -289,517,719 120,334,186
FCF USD 39,085,677 19,733,764 109,344,757 -128,286,362 -38,296,809 61,523,254 289,673,724 548,142,358 418,951,439 855,144,955 457,162,980 1,058,422,847 561,937,557 -30,899,236 239,668,596 228,602,392 244,553,904
OCF USD 52,260,507 57,809,411 170,815,046 112,592,505 128,606,944 205,889,113 453,020,477 674,036,849 702,047,204 1,040,487,154 651,795,325 1,162,761,434 610,365,817 12,763,852 274,181,021 261,615,607 274,175,279

Financial Health - DEBT

Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
YTPD 0.00 0.00 0.00 0.00 0.26 0.09 0.00 0.00 0.43 1.34 4.77 7.74 0.00 0.00 0.00 0.00 0.00
D/E 0.26 0.27 0.32 0.00 0.01 0.01 0.00 0.31 1.06 0.94 0.86 0.72 1.76 0.73 0.82 0.89 0.41
CA/CL 1.49 1.94 1.49 24.90 22.39 10.21 3.42 1.07 0.52 0.57 0.62 0.70 0.67 0.70 0.82 0.78 0.82
TA/TL 2.79 3.28 2.86 29.76 20.12 12.58 6.33 2.70 1.72 1.88 1.88 1.86 1.33 1.75 1.73 1.72 2.19
Total Debt 36,071,674 52,000,000 92,000,000 0 30,000,000 25,000,000 0 950,992,020 3,617,630,463 3,719,993,063 3,570,373,985 3,119,849,673 2,677,543,612 1,352,444,997 1,558,128,882 1,454,973,446 675,689,728

Management Performance

Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
ROIC 42.82% 42.76% 34.05% 7.22% 5.30% 6.82% 6.87% 9.59% 8.48% 8.37% 3.56% 1.63% 7.56% 17.05% 2.74% -3.75% 5.28%
ROE 54.05% 54.60% 45.29% 7.30% 5.39% 7.06% 9.48% 14.69% 19.54% 18.08% 7.42% 2.91% -174.51% 21.67% 2.38% -17.75% 7.24%
ROA 0.00% 37.95% 29.43% 7.05% 5.04% 6.37% 7.80% 9.26% 8.43% 8.40% 3.37% 1.36% -41.43% 9.05% 1.15% -7.11% 4.08%
NM % 45.55% 38.44% 30.29% 26.89% 21.39% 23.17% 17.34% 23.28% 24.79% 24.02% 10.18% 2.30% -52.53% 13.10% 1.43% -9.32% 4.58%
FCF / R% 0.00% 7.16% 25.43% -22.29% -7.01% 8.65% 22.15% 28.76% 15.63% 28.66% 15.03% 19.31% 11.12% -1.01% 7.62% 7.36% 9.31%
FCF / NI% 52.28% 18.63% 83.96% -82.92% -32.87% 37.64% 126.16% 120.30% 59.76% 117.40% 149.76% 821.93% -21.17% -7.56% 445.17% -78.96% 190.02%
Operating Margin (OM) 0.00 0.27 0.36 0.52 0.60 0.67 0.40 0.48 0.55 0.40 0.44 0.25 -0.25 -0.29 -0.35 -0.33 -0.35

Per Share

Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
EPS 0.13 0.07 0.08 0.08 0.06 0.08 0.11 0.21 0.31 0.33 0.14 0.06 -1.21 0.18 0.02 -0.13 0.05
SPS 0.29 0.18 0.27 0.31 0.26 0.34 0.62 0.91 1.25 1.37 1.38 2.49 2.30 1.39 1.43 1.41 1.19
OCPS 0.09 0.04 0.11 0.06 0.06 0.10 0.21 0.32 0.33 0.48 0.30 0.53 0.28 0.01 0.12 0.12 0.12
FCPS 0.07 0.01 0.07 -0.07 -0.02 0.03 0.14 0.26 0.20 0.39 0.21 0.48 0.26 -0.01 0.11 0.10 0.11
BVPS 0.24 0.12 0.18 1.15 1.05 1.13 1.17 1.48 1.62 1.86 1.93 2.00 0.72 0.88 0.90 0.77 0.78

Per Share - CAGR

Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
CAGR-EPS 0.13 0.07 0.08 0.08 0.06 0.08 0.11 0.21 0.31 0.33 0.14 0.06 -1.21 0.18 0.02 -0.13 0.05
CAGR-SPS 0.29 0.18 0.27 0.31 0.26 0.34 0.62 0.91 1.25 1.37 1.38 2.49 2.30 1.39 1.43 1.41 1.19
CAGR-OCPS 0.09 0.04 0.11 0.06 0.06 0.10 0.21 0.32 0.33 0.48 0.30 0.53 0.28 0.01 0.12 0.12 0.12
CAGR-FCPS 0.07 0.01 0.07 -0.07 -0.02 0.03 0.14 0.26 0.20 0.39 0.21 0.48 0.26 -0.01 0.11 0.10 0.11
CAGR-BVPS 0.24 0.12 0.18 1.15 1.05 1.13 1.17 1.48 1.62 1.86 1.93 2.00 0.72 0.88 0.90 0.77 0.78
Revenue $2.63B
3Y
5Y
7Y
10Y
Net Income $120.33M
3Y
5Y
7Y
10Y
Operating Cash Flow $274.18M
3Y
5Y
7Y
10Y
Free Cash Flow $244.55M
3Y
5Y
7Y
10Y
YTPD $0.00
3Y
5Y
7Y
10Y
D/E $0.41
3Y
5Y
7Y
10Y
CA/CL $0.82
3Y
5Y
7Y
10Y
TA/TL $2.19
3Y
5Y
7Y
10Y
ROIC $5.28%
3Y
5Y
7Y
10Y
ROE $7.24%
3Y
5Y
7Y
10Y
ROA $4.08%
3Y
5Y
7Y
10Y
Net Margin $4.58%
3Y
5Y
7Y
10Y
FCF / R% $9.31%
3Y
5Y
7Y
10Y
FCFNI % $190.02%
3Y
5Y
7Y
10Y
Operating Margin $-0.35
3Y
5Y
7Y
10Y
EPS $0.05
3Y
5Y
7Y
10Y
SPS $1.19
3Y
5Y
7Y
10Y
OCPS $0.12
3Y
5Y
7Y
10Y
FCPS $0.11
3Y
5Y
7Y
10Y
BVPS $0.78
3Y
5Y
7Y
10Y
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation